Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-05

Clinical Trial Update: Does Concomitant Use of Combined Oral Hormonal Steroids Stop Bleeding in Women Using Etonogestrel Implants (Implanon/Nexplanon®)?: A Randomized Controlled Study [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluated whether concomitant use of combined oral contraceptives reduces bleeding in women using the etonogestrel implant (Implanon/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Combined oral contraceptives
  • Implanon/Nexplanon (etonogestrel implant) (etonogestrel implant)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Uterine Hemorrhage, Contraception | Phase 2 | Status: COMPLETED | Results posted: 2016-05-05